Nkarta Inc

NKTXNASDAQ NMS - GLOBAL MARKET

Health CareBiotechnology

$3.25

-0.050000 (-1.52%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $1.63Current: $3.2552-Week High: $3.65

Key Statistics

Open

$3.30

Day High

$3.30

Day Low

$3.17

Prev. Close

$3.30

Volume

336.87K

Avg. Volume

—

Market Cap

$232.52M

P/E (TTM)

-2.41

Forward P/E

—

P/B Ratio

—

52W High

$3.65

52W Low

$1.63

50D MA

$2.71

200D MA

$2.27

Dividend Yield

—

Beta

—

Performance

+7.3%

+20.8%

+79.6%

YTD

+73.8%

+87.9%

About

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award (FOYA) award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration (FDA) in December 2023.

www.nkartatx.com/